drugset / Trial / NCT00576316

Symbicort Maintenance and Reliever Therapy - Experience in Real Life Setting in Malaysia

NCT00576316

Phase 4 Completed 201 enrolled AstraZeneca
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to evaluate the satisfaction level of patients using the Symbicort SMART approach for their asthma management.

Timeline

Start
2008-01
Primary completion
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Symbicort Unknown

Indications